Greenspring Associates
United States
234
72M
166
10.17
43
0.29
74
- Stages of investment
- Areas of investment
Summary
In 2000 was created Greenspring Associates, which is appeared as VC. The company was established in North America in United States. The main office of represented VC is situated in the Owings Mills.
The fund was created by Ashton Newhall. Besides them, we counted 7 critical employees of this fund in our database.
The fund is constantly included in 7-12 investment rounds annually. Deals in the range of 50 - 100 millions dollars are the general things for fund. The average startup value when the investment from Greenspring Associates is 500 millions - 1 billion dollars. The top activity for fund was in 2019. The top amount of exits for fund were in 2015. Considering the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Greenspring Associates performs on 18 percentage points more the average number of lead investments.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Greenspring Associates, startups are often financed by Sequoia Capital, Scale Venture Partners, OpenView Venture Partners. The meaningful sponsors for the fund in investment in the same round are e.ventures, Cross Creek, OpenView Venture Partners. In the next rounds fund is usually obtained by Silicon Valley Bank, OpenView Venture Partners, Domain Associates.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Enterprise Software, Health Care. Among the most popular portfolio startups of the fund, we may highlight Alibaba, Intarcia Therapeutics, Zayo. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 234
- Lead investments
- 43
- Exits
- 74
- Rounds per year
- 10.17
- Follow on index
- 0.29
- Investments by industry
- Software (73)
- Health Care (56)
- SaaS (40)
- Biotechnology (37)
- Enterprise Software (36) Show 226 more
- Investments by region
-
- United States (206)
- Germany (2)
- Israel (4)
- Canada (3)
- United Kingdom (4) Show 5 more
- Peak activity year
- 2021
- Number of Unicorns
- 29
- Number of Decacorns
- 31
- Number of Minotaurs
- 9
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Avg. valuation at time of investment
- 959M
- Group Appearance index
- 0.93
- Avg. company exit year
- 10
- Avg. multiplicator
- 3.77
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Imago BioSciences | 19 Nov 2020 | Biotechnology, Medical, Life Science | Late Stage Venture | 80M | United States, California |
TMON | 10 Jan 2011 | E-Commerce, Information Technology, Mobile | Late Stage Venture | 8M | Gyeonggi-do, South Korea, South Korea |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.